Associated Genetic Biomarkers
Associated Diseases


Location [1]
Protein [2]
Nuclear receptor coactivator 2
Synonyms [1]
bHLHe75, SRC2, GRIP1, KAT13C, NCoA-2, TIF2

Nuclear receptor co-activator 2 (NCOA2) is a gene that encodes a protein that functions as a nuclear receptor co-activator - a protein that helps nuclear hormone receptors function properly. Fusions, missense mutations, nonsense mutations, silent mutations, frameshift deletions and insertions, and in-frame deletions are observed in cancers such as endometrial cancer, intestinal cancer, and pleural cancer.

NCOA2 is altered in 0.28% of all cancers with breast invasive ductal carcinoma, conventional glioblastoma multiforme, lung adenocarcinoma, colon adenocarcinoma, and bladder urothelial carcinoma having the greatest prevalence of alterations [3].

NCOA2 GENIE Cases - Top Diseases

The most common alterations in NCOA2 are NCOA2 Fusion (0.04%), NCOA2 Q82H (0.18%), NCOA2 A1166T (0.77%), NCOA2 D824E (0.77%), and NCOA2 E594dup (0.15%) [3].

NCOA2 GENIE Cases - Top Alterations

Significance of NCOA2 in Diseases

Mesenchymal Chondrosarcoma +


1. Hart R and Prlic A. Universal Transcript Archive Repository. Version uta_20180821. San Francisco CA: Github;2015.

2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.

3. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.

4. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.